Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

Launch of New Superparamagnetic Material

27 Jun 2022 07:00

RNS Number : 2042Q
Versarien PLC
27 June 2022
 

Reach - Non-Regulatory

27 June 2022

 

Versarien plc

("Versarien" or the "Company" or the "Group")

Launch of New Superparamagnetic Material

Graphene based material to support a range of applications across electronics, sustainability and biotechnology

Versarien plc (AIM: VRS), the advanced engineering materials group, announces the launch of a new hybrid nanomaterial that has superparamagnetic properties, which can be used across a range of applications, such as in defence and healthcare.

The development of the material has been led by Versarien's 62% owned subsidiary, Gnanomat S.L. ("Gnanomat"), whose research has pioneered the generation of a new family of versatile nanocomposites based on graphene and other forms of carbon, combined with metal or metal oxide nanoparticles typically intended for energy storage applications.

The superparamagnetic material combines graphene with both iron oxide and manganese oxide nanoparticles that provide the material with magnetic properties. In return, graphene provides electrical conductivity to these electrically insulating metal oxides. Magnetic nanocomposites can readily respond to external magnetic fields which allow them to be manipulated. Potential applications of the material include the treatment of wastewater whereby pollutants are adsorbed onto the graphene surface. The material also lends itself to biomedical and biotechnology applications, or defence applications requiring the shielding of electromagnetic fields. Magnetic manipulation could allow the recovery and recycling of the graphene, something that could not be done with normal graphene compounds.

For more information, or to purchase the material visit https://gnanomat.com/products-2/

Commenting, Versarien CEO, Neill Ricketts, said: "Our superparamagnetic material is the next product for Versarien to launch with its focus on providing efficient and sustainable solutions. Our research and development teams across the Group have been working over the last few years to optimise the use of graphene, and we're pleased to be bringing the next phase of graphene materials to market."

Steve Hodge, CTO at Versarien, commented: "The potential for this material is hugely promising. Versarien is branching out into the next generation of nanomaterials, providing innovation to industries across the globe. The technical properties the superparamagnetic material offers are exciting and show that there is so much more potential for us to find innovative applications for other nanomaterials."

Roberto Clemente, CEO of Gnanomat, said: "We believe this is the beginning of the next wave of nanomaterials. Using graphene combined with metal oxides, there are countless opportunities to change the way we view a number of industries. This superparamagnetic material is just the first step in an extensive line of innovation to come."

 

For further information please contact:

Versarien

+44 (0) 1594 887204

Neill Ricketts, CEO, Chris Leigh CFO

SP Angel Corporate Finance (Nominated Adviser and Joint Broker)

+44 (0)20 3470 0470

Matthew Johnson, Ewan Leggat, Adam Cowl

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Ciaran Walsh

IFC Advisory Limited (Financial PR and Investor Relations)

 +44 (0) 20 3934 6630

Tim Metcalfe, Zach Cohen

 

About Versarien:

The strategy of Versarien Plc (AIM:VRS) is to be a globally recognised graphene company with a wide portfolio of high-quality verified materials allied to the largest relevant IP portfolio supported by its own UK based research and development centre driving recurring revenue growth through its innovative graphene product applications.

For further information please see: http://www.versarien.com

 

About Gnanomat:

Gnanomat develops and manufactures engineered graphene-based nanomaterials to address different industrial applications with special emphasis in Energy Storage. The mission of Gnanomat is to obtain ESS (Energy Storage Systems) with higher energy storage capacity. We address this mission through a new generation of nanomaterials portfolio.

For further information please see: www.gnanomat.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASEUFLMEESEFM
Date   Source Headline
9th Feb 20267:00 amRNSCancellation - Versarien Plc
6th Jan 20261:34 pmRNSAppointment of Administrators
19th Dec 20254:36 pmRNSUpdate on NOIA
19th Dec 20254:36 pmRNSUpdate on NOIA
15th Dec 20253:53 pmRNSUpdate on the Disposal of AAC Cyroma Limited
12th Dec 20257:00 amRNSUpdate on NOIA and Change of Registered Office
1st Dec 20257:30 amRNSSuspension - Versarien plc
1st Dec 20257:00 amRNSIntention to Appoint Administrators, Suspension
26th Nov 20257:00 amRNSUpdate - Proposed Disposal of the Company's Assets
31st Oct 20258:48 amRNSProposed Disposal of the Company’s Assets
29th Sep 20252:32 pmRNSCorporate Update
10th Sep 20251:00 pmRNSCorporate Update
29th Aug 20252:19 pmRNSCorporate Update
21st Aug 20257:00 amRNSStrategic Investment and Joint Venture Update
11th Aug 20257:00 amRNSCorporate Update
5th Aug 202511:03 amRNSHolding(s) in Company
29th Jul 20257:00 amRNSCorporate Update
22nd Jul 202510:55 amRNSSettlement of Legal Claims
4th Jul 20257:00 amRNS-RSouth American Polygrene™ Themoplastics Agreements
30th Jun 20253:03 pmRNSInterim Results
19th Jun 20252:34 pmRNSBuilding for Humanity – Contract Update
4th Jun 202511:49 amRNSHolding(s) in Company
2nd Jun 20252:03 pmRNSHolding(s) in Company
30th May 202510:19 amRNSHolding(s) in Company
30th May 20257:00 amRNSTotal Voting Rights
29th May 20253:29 pmRNSHolding(s) in Company
29th May 202510:20 amRNSHolding(s) in Company
27th May 202511:59 amRNSHolding(s) in Company
27th May 202511:02 amRNSHolding(s) in Company
23rd May 20259:38 amRNSHolding(s) in Company
22nd May 202511:56 amRNSHolding(s) in Company
21st May 202510:58 amRNSHolding(s) in Company
20th May 202511:11 amRNSHolding(s) in Company
14th May 20257:00 amRNSPlacing to raise £425,000
2nd May 202511:00 amRNSUpdate on Legal Claims
28th Apr 20251:04 pmRNSResult of AGM
27th Mar 20257:00 amRNSAudited Results for year ended 30 September 2024
24th Mar 202511:24 amRNSResult of General Meeting
10th Mar 20257:00 amRNS-RGraphinks™ supply agreement with Montana Química
5th Mar 20257:00 amRNSNotice of General Meeting
3rd Mar 20257:00 amRNSCompletion of Sale of Korean Assets
28th Feb 20257:00 amRNSTotal Voting Rights
27th Feb 20257:00 amRNSInnovate UK Loan Deed of Variation
10th Feb 20258:35 amRNSHolding(s) in Company
28th Jan 20252:36 pmRNSPlacing to raise £246k
30th Dec 202412:00 pmRNSUpdate on Sale of Korean Assets
13th Dec 20242:58 pmRNSHolding(s) in Company
13th Dec 202411:50 amRNSHolding(s) in Company
13th Dec 202410:11 amRNSHolding(s) in Company
13th Dec 20247:00 amRNS€804,000 Grant Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.